FilingReader Intelligence

Shyndec Pharma revamps governance: Board changes, articles amended

June 11, 2025 at 11:38 PM UTCBy FilingReader AI

Shanghai Shyndec Pharmaceutical [SSE:600420] is undertaking a significant overhaul of its corporate governance structure, according to a new filing. The company will eliminate its board of supervisors, transferring its duties to the audit and risk management committee under the board of directors. Additionally, the board will now include one employee representative. These changes will be put to shareholders for approval.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Shanghai Shyndec Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →